Response to anti-VEGF therapy in macular oedema secondary to acute retinal necrosis.

Response to anti-VEGF therapy in macular oedema secondary to acute retinal necrosis.
Arch Soc Esp Oftalmol. 2018 Oct 15;:
Authors: Sánchez Ramón A, Piñón Mosquera R, Mendieta Rasos N
Abstract
A 55 year-old female patient with unilateral Acute Retinal Necrosis (ARN) developed macular oedema (MO) after the resolution of her necrosis. The macular oedema (MO) was managed and controlled for four years with intravitreal anti-VEGF injections. Anti-VEGF therapy could be useful for the treatment of MO secondary to ARN, the same as for treating MO resulting from panuveitis, where its efficacy has been already demonstrated.
PMID: 30337096 [PubMed - as supplied by publisher]

Source: Archivos de la Sociedad Espanola de Oftalmologia - October 21, 2018 Category: Opthalmology Tags: Arch Soc Esp Oftalmol Source Type: research